Research Paper Volume 16, Issue 8 pp 6954—6989
Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification
Figure 2. Expression of LAPTM4A in glioma. (A) The expression level of LAPTM4A in different types of tumor tissues and normal tissues in the TIMER database. (p < 0.05) (B–D) Expression levels of LAPTM4A were higher than corresponding normal tissues in LGG, GBM, and GBMLGG samples. The box plot showed the association of LAPTM4A expression with clinicopathological characteristics. (E) WHO grade, (F) Histological type, (G) IDH status, (H) 1p/19q codeletion, (I) Age, (J) Gender, (K) OS event, (L) Primary therapy outcome.